Skip to main content

CITADEL ADVISORS LLC

Position in FHTX — Foghorn Therapeutics Inc.

CIK 1423053 MIAMI, FL

Position in FHTX

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$775,051
-$181,010 QoQ
Shares Held
158,822
-20.6% QoQ
Ownership
0.267%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#25
of 102 holders
Holding Since
Dec 2021
12 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in FHTX Over Time

Shares Held

Position Value (USD)

Derivatives in FHTX

reported options exposure · as of Sep 30, 2024
CallValue
$80,066
CallShares
8,600
PutValue
$22,344
PutShares
2,400

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

CITADEL ADVISORS LLC holds $6,088,855,369 across 436 Biotechnology names. FHTX ranks #250 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in FHTX

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $775,051 158,822
2026-03-31 $956,061 200,013
2025-12-31 $984,289 182,276
2025-09-30 $58,812 12,027
2024-09-30 $22,344 2,400
2024-09-30 $756,009 81,204
2024-09-30 $80,066 8,600
2024-06-30 $33,925 5,900
2024-06-30 $10,350 1,800
2024-06-30 $372,887 64,850
2024-03-31 $160,858 23,973
2024-03-31 $9,394 1,400
2024-03-31 $50,996 7,600
2023-03-31 $949,046 153,072
2023-03-31 $17,360 2,800
2023-03-31 $3,100 500
2022-12-31 $406,922 63,781
2022-12-31 $252,010 39,500
2022-12-31 $14,674 2,300
2022-09-30 $327,756 38,200
2022-09-30 $580,797 67,692
2022-03-31 $891,655 58,546
2021-12-31 $274,440 12,000